Increased tumor-specific CD8+ T cell induction by dendritic cells matured with a clinical grade TLR-agonist in combination with IFN-gamma.

Vanderlocht, J; Van Elssen, C H M J; Senden-Gijsbers, B L M G; Meek, B; Cloosen, S; Libon, C; Bos, G M J; Germeraad, W T V

Vanderlocht, J; Van Elssen, C H M J; Senden-Gijsbers, B L M G; Meek, B; Cloosen, S; Libon, C; Bos, G M J; Germeraad, W T V.

Affiliation

Vanderlocht J; Department of Internal Medicine, Division of Haematology, Maastricht University Medical Center, Maastricht, The Netherlands. j.vanderlocht@immuno.unimaas.nl

Int J Immunopathol Pharmacol ; 23(1): 35-50, 2010.

Article in En | MEDLINE | ID: mdl-20377993

Subject(s)

CD8-Positive T-Lymphocytes/immunology; Dendritic Cells/physiology; Interferon-gamma/pharmacology; Neoplasms/immunology; Toll-Like Receptors/agonists; Cell Movement; Cytokines/biosynthesis; Dendritic Cells/drug effects; Dendritic Cells/immunology; Humans; Immunologic Memory; Mucin-1/immunology; T-Lymphocytes, Helper-Inducer/immunology

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Dendritic Cells / Interferon-gamma / CD8-Positive T-Lymphocytes / Toll-Like Receptors / Neoplasms Type of study: Guideline / Prognostic_studies Limits: Humans Language: En Journal: Int J Immunopathol Pharmacol Journal subject: ALERGIA E IMUNOLOGIA / FARMACOLOGIA / PATOLOGIA Year: 2010 Document type: Article Affiliation country: Netherlands Country of publication: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links